pentetic acid and Breast Cancer studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Research Excerpts

Excerpt	Relevance	Reference
"To evaluate the diagnostic utility of a single vial ready to label with [99m]Tc kit preparation of DTPA-bis-methionine (DTPA-bis-MET) for the detection of primary breast cancer."	7.80	LAT-1 based primary breast cancer detection by [99m]Tc-labeled DTPA-bis-methionine scintimammography: first results using indigenously developed single vial kit preparation. ( Abrar, ML; Chopra, S; Chuttani, K; Hazari, PP; Mishra, AK; Mittal, BR; Rathod, D; Sharma, S; Singh, B; Singh, G; Singh, PM, 2014)
"The epidermal growth factor receptor (EGFR) is an attractive target for the design of radiotherapeutic agents for breast cancer because it is present on almost all estrogen receptor-negative, hormone-resistant tumors with a poor prognosis."	7.72	Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. ( Cameron, R; Chen, P; Reilly, RM; Vallis, KA; Wang, J, 2003)
" We evaluated the efficacy of combined treatment with continuous administration of topotecan and 90Y-MX-DPTA BrE3 monoclonal antibody (which recognizes an epitope of breast epithelial mucin expressed in most breast cancers) on human mammary carcinoma xenografts in nude mice."	7.71	Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts. ( Blank, E; Ceriani, R; Furmanski, P; Hochster, H; Kramer, E; Liebes, L; Ng, B; Wasserheit, C, 2001)
"This study was designed to assess the efficacy of dynamic contrast-enhanced magnetic resonance imaging (MRI) of the breast combined with pharmacokinetic analysis of gadolinium (Gd)-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma."	7.69	Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma. ( Bowsley, SJ; Buckley, DL; Carleton, PJ; Fox, JN; Horsman, A; Mussurakis, S; Turnbull, LW, 1995)
" (111)In-DTPA-hEGF was cleared rapidly from the blood, with a half-life at alpha-phase of 2."	5.33	Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. ( Cameron, R; Chen, P; Reilly, RM; Scollard, D; Vallis, KA; Wang, J, 2006)
"Metastasis is the principal cause of death in breast cancer patients."	5.31	In vitro cytotoxicity of bismuth-213 (213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cells. ( Allen, BJ; Andronicos, NM; Ranson, M; Rizvi, S; Tian, Z, 2002)
"It was concluded that in brain metastases of mammary carcinoma Lact represents a product of ischemia preceding/during tissue decay resulting in central necrosis, rather than tumor specific metabolism resulting in increased glycolysis."	5.29	Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma. ( Oudkerk, M; Sijens, PE; van Dijk, P, 1994)
"To evaluate the diagnostic utility of a single vial ready to label with [99m]Tc kit preparation of DTPA-bis-methionine (DTPA-bis-MET) for the detection of primary breast cancer."	3.80	LAT-1 based primary breast cancer detection by [99m]Tc-labeled DTPA-bis-methionine scintimammography: first results using indigenously developed single vial kit preparation. ( Abrar, ML; Chopra, S; Chuttani, K; Hazari, PP; Mishra, AK; Mittal, BR; Rathod, D; Sharma, S; Singh, B; Singh, G; Singh, PM, 2014)
"MDA-MB-468 human breast cancer cells were treated overnight with (111)In-diethylenetriaminepentaacetic acid human epidermal growth factor ((111)In-DTPA-hEGF, 0-142 kBq/pmol) or exposed to gamma-radiation to induce DNA double strand breaks (DSB)."	3.75	Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software. ( Cai, Z; Reilly, RM; Vallis, KA, 2009)
"The increased expression of the neurotensin (NT) receptor NTS1 by different cancer cells, such as pancreatic adenocarcinoma and ductal breast cancer cells, as compared to normal epithelium, offers the opportunity to target these tumors with radiolabeled neurotensin analogues for diagnostic or therapeutic purposes."	3.75	Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors. ( Abdelhak, J; Alshoukr, F; Barbet, J; Burg, S; Gruaz-Guyon, A; Maes, V; Pelaprat, D; Raguin, O; Rosant, C; Sarda, L; Tourwé, D, 2009)
" Toremifene [TOR; 4-chloro-1,2-diphenyl-1-(4-(2-(N,N-di-methylamino)ethoxy)phenyl)-1-butene, as citrate salt] was selected as the starting material to be derived, since it has been used extensively as an antiestrogen drug for treatment and prevention of human breast cancer."	3.75	Synthesis of a novel antiestrogen radioligand (99mTc-TOR-DTPA). ( Acar, C; Enginar, H; Muftuler, FZ; Unak, P; Yolcular, S; Yurt, A, 2009)
"Our objective was to evaluate the effect of epidermal growth factor receptor(s) (EGFR) density on the importation and nuclear localization of 111In-labeled diethylenetriaminepentaacetic acid human epidermal growth factor ([111In]DTPA-hEGF) in breast cancer (BC) cells in vitro and in tumor xenografts and normal tissues in vivo in athymic mice, as well as on its cytotoxicity and tumor and normal-tissue distribution."	3.74	Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF. ( Chan, C; Chen, P; Hu, M; Reilly, RM; Scollard, D; Vallis, K, 2007)
"Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic breast cancer underwent gamma camera imaging from 15 minutes to 7 days after injection of 150 MBq 111In-diethylenetriamine penta-acetic acid anhydride (DTPA) -trastuzumab, after loading-dose trastuzumab, and after once-a-week trastuzumab doses for 11 weeks, and concomitant paclitaxel once every 3 weeks."	3.73	Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. ( de Korte, MA; de Vries, EG; Gietema, JA; Jager, PL; Jonkman, S; Kosterink, JG; Lub-De Hooge, MN; Perik, PJ; Sleijfer, DT; van der Graaf, WT; van Veldhuisen, DJ, 2006)
"The epidermal growth factor receptor (EGFR) is an attractive target for the design of radiotherapeutic agents for breast cancer because it is present on almost all estrogen receptor-negative, hormone-resistant tumors with a poor prognosis."	3.72	Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. ( Cameron, R; Chen, P; Reilly, RM; Vallis, KA; Wang, J, 2003)
" We evaluated the efficacy of combined treatment with continuous administration of topotecan and 90Y-MX-DPTA BrE3 monoclonal antibody (which recognizes an epitope of breast epithelial mucin expressed in most breast cancers) on human mammary carcinoma xenografts in nude mice."	3.71	Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts. ( Blank, E; Ceriani, R; Furmanski, P; Hochster, H; Kramer, E; Liebes, L; Ng, B; Wasserheit, C, 2001)
"Our objective was to compare 111In-labeled human epidermal growth factor (hEGF), a 53-amino acid peptide with anti-epidermal growth factor receptor (EGFR) monoclonal antibody (MAb) 528 (IgG2a) for imaging EGFR-positive breast cancer."	3.70	A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. ( Cameron, RG; Gariépy, J; Hendler, A; Kiarash, R; Lee, YW; Reilly, RM; Sandhu, J; Vallis, K, 2000)
"This study was designed to assess the efficacy of dynamic contrast-enhanced magnetic resonance imaging (MRI) of the breast combined with pharmacokinetic analysis of gadolinium (Gd)-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma."	3.69	Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma. ( Bowsley, SJ; Buckley, DL; Carleton, PJ; Fox, JN; Horsman, A; Mussurakis, S; Turnbull, LW, 1995)
"Delayed gadolinium-enhanced MR images can help define the extent of laser-induced necrosis and residual tumor after interstitial laser photocoagulation therapy in breast cancer."	3.69	Laser therapy for breast cancer: MR imaging and histopathologic correlation. ( Amin, Z; Bown, SG; Buonaccorsi, G; Davidson, TI; Hall-Craggs, MA; Kissin, MW; Mumtaz, H; Paley, M; Taylor, I; Wilkinson, I; Wotherspoon, A, 1996)
"Eleven patients with breast cancer participated in this study."	2.74	Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol. ( Darrah, DD; Hoh, CK; Limmer, KK; Schulteis, G; Vera, DR; Wallace, AM, 2009)
"Ten patients with breast cancer participated in this study."	2.73	Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek. ( Darrah, DD; Hoh, CK; Schulteis, G; Vera, DR; Wallace, AM, 2007)
"Twenty-four female breast cancer patients participated in this study."	2.71	Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping. ( Darrah, DD; Ellner, SJ; Hoh, CK; Schulteis, G; Vera, DR; Wallace, AM, 2003)
"Twelve women (42-71 years) with breast cancer were randomly assigned to a 3-hour imaging protocol with peritumoral/subdermal injections (."	2.71	Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. ( Darrah, DD; Hoh, CK; Schulteis, G; Vera, DR; Wallace, AM, 2003)
"Patients with CEA-producing breast cancer refractory to standard therapies underwent peripheral stem cell collection followed by infusion of 111indium-DTPA-cT84."	2.69	Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer. ( Doroshow, JH; Forman, S; Liu, A; Odom-Maryon, T; Raubitschek, AA; Shively, JE; Somlo, G; Wilczynski, S; Williams, LE; Wong, JY; Wu, AM; Yamauchi, D; Yazaki, P, 1999)
"Distant metastases from carcinoid tumours are correlated with poor prognosis and survival."	2.40	Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide. ( Besser, GM; Britton, KE; Grossman, AB; Kaltsas, GA; Lowe, DG; Monson, JP; Mukherjee, JJ; Putignano, P; Satta, MA, 1998)
"There are indications that breast carcinomas, of which some express the somatostatin receptor (SS-R), can be divided this way."	2.40	Somatostatin receptors and breast cancer. ( Krenning, EP; Kwekkeboom, DJ; van Eijck, CH, 1998)
"For in vivo studies, a human breast cancer cell line (MDA-231) was implanted in five mice per group."	1.48	Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging. ( Boehm-Sturm, P; Haeckel, A; Hauptmann, R; Kuhl, CK; Mueller, S; Schellenberger, EA, 2018)
"MDA-MB-468 and MDA-MB-231/H2N (231-H2N) breast cancer cells were incubated with (111)In-DTPA-anti-γH2AX-Tat (3MBq, 6MBq/μg) or a control radioimmunoconjugate, (111)In-DTPA-mIgG-Tat, and exposed to IR or bleomycin."	1.38	Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical. ( Allen, D; Barbeau, J; Cornelissen, B; Darbar, S; Falzone, N; Kersemans, V; Smart, S; Vallis, KA, 2012)
"In irradiated breast cancer cells, confocal microscopy confirmed the expected colocalization of anti-γH2AX-Tat with γH2AX foci."	1.37	Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates. ( Cornelissen, B; Darbar, S; Hill, MA; Kersemans, V; Shah, K; Sleeth, K; Thompson, J; Vallis, KA, 2011)
"Treatment of breast cancer cells with different concentrations of a cell membrane permeable zinc chelator, N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) and the membrane impermeable zinc chelator, diethylenetriaminepentacetic acid, (DTPA) resulted in a significant increase of cell death."	1.34	Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells. ( Booy, EP; Eshraghi, M; Ghavami, S; Hashemi, M; Los, M, 2007)
" (111)In-DTPA-hEGF was cleared rapidly from the blood, with a half-life at alpha-phase of 2."	1.33	Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. ( Cameron, R; Chen, P; Reilly, RM; Scollard, D; Vallis, KA; Wang, J, 2006)
"Some breast tumors are classified as primary neuroendocrine carcinomas because of argyrophilia and positivity for neuroendocrine markers (chromogranins A and B and neuron-specific enolase), regardless of their cellular rest and cord structures."	1.31	Tc-99m sestamibi and In-111 DTPA octreotide uptake in breast carcinoma with neurendocrine differentiation. ( D'Eredità, G; Rubini, G, 2000)
" It has approximately 130 min of half-life of blood TFO."	1.31	Pharmacokinetics of (111)In-labeled triplex-forming oligonucleotide targeting human N-myc gene. ( Cho, JG; Kim, MK; Oh, EJ; Park, GH; Park, MK; Sohn, J; Yoon, EJ, 2002)
"Metastasis is the principal cause of death in breast cancer patients."	1.31	In vitro cytotoxicity of bismuth-213 (213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cells. ( Allen, BJ; Andronicos, NM; Ranson, M; Rizvi, S; Tian, Z, 2002)
"6 Gy to breast cancer cells producing growth inhibition equivalent to 4 Gy of gamma-radiation."	1.31	Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells. ( Cameron, R; Chen, P; Hendler, A; Mrkobrada, M; Reilly, RM; Sandhu, J; Vallis, KA, 2002)
"Of the 20 primary breast cancer specimens analyzed, three tumors (approximately 15%) were positive for sst1, nine (approximately 45%) revealed immunoreactive sst2A receptors, eight (approximately 40%) showed sst3-like immunoreactivity, and 14 (approximately 70%) were positive for sst5."	1.31	True positive somatostatin receptor scintigraphy in primary breast cancer correlates with expression of sst2A and sst5. ( Franke, K; Helmholz, T; Otto, HJ; Schmitt, J; Schulz, S; Weise, W, 2002)
"Histopathology revealed 17 breast carcinomas (15 cases of invasive ductal carcinoma, one mucinous adenocarcinoma and one intraductal carcinoma) and four benign breast lesions (two fibroadenomas, one abscess and one case of fat necrosis)."	1.30	Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of having breast cancer: preliminary results. ( Atasever, T; Gökçora, N; Ozdemir, A; Ozur, I; Unlü, M; Vural, G, 1997)
"A total of 190 patients with breast cancer (37 noninvasive carcinomas, 153 invasive carcinomas) underwent dynamic contrast-enhanced MR mammography preoperatively."	1.30	Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. ( Brinck, U; Fischer, U; Grabbe, E; Kopka, L; Korabiowska, M; Schauer, A, 1997)
"In 11 patients with previous breast cancer, scintimammographic findings were positive in all four with tumor recurrence and negative in all seven with benign disease."	1.30	Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. ( Ennis, JT; Fenlon, HM; Gorey, T; O'Sullivan, P; Phelan, NC; Tierney, S, 1997)
"The in vivo response of MCF-7 breast cancer xenografts to tamoxifen and DTPA-Tam in nude mice demonstrated that DTPA-Tam could reduce tumor growth rate."	1.29	Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue. ( Cherif, A; Delpassand, ES; Inoue, T; Joubert, A; Podoloff, DA; Price, J; Quadri, SM; Wallace, S; Yang, DJ, 1996)
"Cubic volumes containing brain metastases of lung cancer (n = 17), mammary carcinoma (n = 24), melanoma (n = 12) and those originating from other tumors (n = 13) were examined using the double spin echo technique with CHESS pulses for water suppression and TE = 135 ms."	1.29	1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. ( Levendag, PC; Oudkerk, M; Sijens, PE; van Dijk, P; Vecht, CJ, 1996)
"It was concluded that in brain metastases of mammary carcinoma Lact represents a product of ischemia preceding/during tissue decay resulting in central necrosis, rather than tumor specific metabolism resulting in increased glycolysis."	1.29	Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma. ( Oudkerk, M; Sijens, PE; van Dijk, P, 1994)
" On the basis of the mathematically established and experimentally verified linear relationship between the measured saturation recovery TurboFLASH signal variation and the gadolinium diethylenetriaminopentaacetic acid concentration in the tissue, the signal-time courses were analyzed within the framework of pharmacokinetic modeling."	1.29	Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. ( Brix, G; Hess, T; Hoffmann, U; Knopp, MV; Lorenz, WJ, 1995)
"The multifocality of breast cancers can be recognized only with MRM."	1.29	False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid. ( Kaiser, WA, 1994)
" The signal changes were analysed using a pharmacokinetic model which allowed parametrization of the contrast enhancement and transformation of the data into colour coded parameter images."	1.29	[A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma]. ( Brix, G; Hess, T; Hoffmann, U; Junkermann, H; Knopp, MV; van Kaick, G; von Fournier, D; Zuna, I, 1994)
"20 women with suspected recurrent breast cancer who had undergone previous breast-conserving operations were investigated using dynamic contrast-enhanced gradient echo (GRE) and fat suppressed spin echo (SE) magnetic resonance (MR) imaging."	1.29	Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience. ( Bowsley, SJ; Carleton, PJ; Cook, AM; Fox, JN; Horsman, A; Imrie, MJ; Kerslake, RW, 1994)
"The two false positive results involved fat necrosis and a foreign-body reaction respectively."	1.29	Magnetic resonance imaging in potential postsurgical recurrence of breast cancer: pitfalls and limitations. ( Bukhanov, K; Cohen, EK; Fishell, EK; Leonhardt, CM; Plewes, DB; Shumak, RS; Soutar, IC, 1996)
"Seventeen patients with invasive breast cancer underwent MRI at 1."	1.29	Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. ( Budnick, RM; Herman, S; Klippenstein, DL; Stewart, CC; Stomper, PC; Winston, JS, 1996)
"The histologic type of breast cancer was well reflected in the enhancement pattern."	1.29	[Fat suppressed dynamic MR imaging of breast cancer: radiologic-pathologic correlation]. ( Kawashima, H, 1996)
"In 23 breast cancers and six fibroadenomas, spin echo T1 images were obtained at 0."	1.29	[Subtraction and dynamic MR images of breast cancer]. ( Aoki, M; Harada, J; Murakami, Y, 1993)
"Breast cancer was confirmed by histopathology in 27 of the patients (22 palpable and 5 non-palpable carcinomas)."	1.29	Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. ( Bender, H; Biersack, HJ; Grünwald, F; Krebs, D; Mallmann, P; Palmedo, H; Schomburg, A, 1996)
"Twenty-two patients with breast cancers were studied using magnetic resonance (MR) imaging with a cylindrical surface coil at 1."	1.28	[Enhanced MRI of breast cancer smaller than 3 cm]. ( Hirota, S; Ikeda, Y; Koizumi, T; Mieda, C; Motohara, T; Narabayashi, I; Ogawa, K; Oshitani, T; Ueda, E; Yoshida, S, 1991)
"In this study, the breast carcinoma-reactive monoclonal antibody 15A8 and a site-specific immunoconjugate of the antibody, 15A8-glycyl-tyrosyl-(N-epsilon-diethylenetriamine pentaacetic acid)-lysine (15A8-GYK-DTPA), were characterized by immunohistological methods for reactivity with normal and neoplastic human tissues and normal cynomolgus monkey tissues."	1.28	Immunohistochemical and pharmacokinetic characterization of site-specific immunoconjugate 15A8-glycyl-tyrosyl-(N-epsilon-diethylenetriamine pentaacetic acid)-lysine derived from anti-breast carcinoma monoclonal antibody 15A8. ( D'Aleo, CJ; Davis, WL; Gilman, SC; Lopes, AD; Rosenstraus, MJ, 1991)
"All ten patients with skeletal metastases had positive 111In-DTPA-M8 scans, but the correlation with X-rays and MDP scans showed a regional variation."	1.27	The localization of human breast carcinomas by radiolabelled monoclonal antibodies. ( Rainsbury, RM, 1984)
"Human breast carcinoma implanted in ten nude mice was studied before and after injection of Gd-DTPA at two different doses (0."	1.27	Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. ( Brasch, RC; Engelstad, B; Fox, P; Grodd, W; Paajanen, H; Revel, D; Rosenau, W; Winkelhake, J, 1986)
"A metastasis from a breast carcinoma developed in the cervical cord."	1.27	[Isolated cervical intramedullary metastasis from breast cancer. Value of magnetic resonance imaging]. ( Cornu, P; Doyon, D; Gautier, JC; Jacquillat, C; Khayat, D; Lauvin, R; Philippon, J, 1988)
"Breast cancer was diagnosed in 94 patients, benign diseases in 63."	1.27	[Thermographic and radionuclide studies in the combined diagnosis of breast cancer]. ( Abushakhmanova, AKh, 1986)
" Changes in relaxation times in normal and abnormal tissues following contrast medium, toxicity and dosage of gadolinium-DTPA, and MRI pulse sequence techniques are reviewed."	1.27	Contrast-enhanced magnetic resonance imaging of tumours of the central nervous system: a clinical review. ( Graif, M; Steiner, RE, 1986)

Research

Studies (184)

Authors

Clinical Trials (7)

Trial Overview

Trial Outcomes

Concordance of Blue Dye and Lymphoseek

Timeframe	Studies, this research(%)	All Research%
pre-1990	24 (13.04)	18.7374
1990's	105 (57.07)	18.2507
2000's	34 (18.48)	29.6817
2010's	21 (11.41)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Boehm-Sturm, P	1
Haeckel, A	1
Hauptmann, R	1
Mueller, S	1
Kuhl, CK	4
Schellenberger, EA	1
Bhattacharyya, S	1
Kurdziel, K	1
Wei, L	1
Riffle, L	1
Kaur, G	1
Hill, GC	1
Jacobs, PM	1
Tatum, JL	1
Doroshow, JH	2
Kalen, JD	1
Chan, C	3
Cai, Z	4
Reilly, RM	15
Holloway, CM	2
Scollard, DA	3
Caldwell, CB	1
Ehrlich, L	1
Kahn, HJ	1
Sharma, S	1
Singh, B	1
Mishra, AK	2
Rathod, D	1
Hazari, PP	1
Chuttani, K	1
Chopra, S	1
Singh, PM	1
Abrar, ML	1
Mittal, BR	1
Singh, G	1
Kojima, C	1
Niki, Y	1
Ogawa, M	1
Magata, Y	1
Pujatti, PB	1
Foster, JM	1
Finucane, C	1
Hudson, CD	1
Burnet, JC	1
Pasqualoto, KFM	1
Mengatti, J	1
Mather, SJ	1
de Araújo, EB	1
Sosabowski, JK	1
Li, HK	1
Morokoshi, Y	1
Daino, K	1
Furukawa, T	1
Kamada, T	1
Saga, T	2
Hasegawa, S	1
Timur, SS	1
Bhattarai, P	1
Gürsoy, RN	1
Vural, İ	2
Khaw, BA	1
Namwongprom, S	1
Wong, FC	1
Tateishi, U	1
Kim, EE	1
Boonyaprapa, S	1
Chen, Z	1
Bailey, KE	1
Vallis, KA	9
Alshoukr, F	1
Rosant, C	1
Maes, V	1
Abdelhak, J	1
Raguin, O	1
Burg, S	1
Sarda, L	1
Barbet, J	1
Tourwé, D	1
Pelaprat, D	1
Gruaz-Guyon, A	1
Wallace, AM	5
Hoh, CK	4
Limmer, KK	1
Darrah, DD	4
Schulteis, G	4
Vera, DR	5
Cornelissen, B	4
Kersemans, V	4
McLarty, K	1
Tran, L	2
Fonge, H	3
Lee, H	1
Allen, C	2
Yurt, A	1
Muftuler, FZ	1
Unak, P	2
Yolcular, S	1
Acar, C	1
Enginar, H	1
Leong, SP	1
Kim, J	1
Ross, M	1
Faries, M	1
Scoggins, CR	1
Metz, WL	2
Cope, FO	2
Orahood, RC	1
Kilcar, AY	1
Biber Muftuler, FZ	1
Avci, CB	1
Gunduz, C	1
Darbar, S	2
Thompson, J	1
Shah, K	1
Sleeth, K	1
Hill, MA	1
Huang, H	1
Scollard, D	3
Tokin, CA	1
Blue, MS	1
Potter, BM	1
Abbruzzese, BC	1
Hartman, RD	1
Joy, MT	1
King, DW	1
Christman, LA	1
Fasih, A	1
Leyton, JV	1
Tikhomirov, I	1
Done, SJ	1
Allen, D	1
Falzone, N	1
Barbeau, J	1
Smart, S	1
Liu, P	1
Boyle, AJ	1
Lu, Y	1
Winnik, MA	1
Able, S	1
Waghorn, PA	1
Myhra, S	1
Jurkshat, K	1
Crossley, A	1
Liko, F	1
Erdoğan, S	1
Özer, YA	1
Chen, P	4
Mrkobrada, M	1
Cameron, R	3
Sandhu, J	2
Hendler, A	2
Cho, JG	1
Kim, MK	1
Oh, EJ	1
Yoon, EJ	1
Sohn, J	1
Park, MK	1
Park, GH	1
Iznaga-Escobar, N	1
Figueredo, R	1
Jain, VK	1
Dwarakanath, BS	1
Pérez-Rodríguez, R	1
Sharma, RK	1
Mathew, TL	1
Hashemi, SH	1
Benjegård, SA	1
Ahlman, H	1
Wängberg, B	1
Forssell-Aronsson, E	1
Billig, H	1
Nilsson, O	1
Blend, MJ	1
Stastny, JJ	1
Swanson, SM	1
Brechbiel, MW	3
Wang, J	2
Ellner, SJ	1
Lub-de Hooge, MN	2
Kosterink, JG	2
Perik, PJ	2
Nijnuis, H	1
Bart, J	1
Suurmeijer, AJ	1
de Jong, S	1
Jager, PL	2
de Vries, EG	2
Adams, GP	1
Shaller, CC	1
Dadachova, E	1
Simmons, HH	1
Horak, EM	1
Tesfaye, A	1
Klein-Szanto, AJ	1
Marks, JD	1
Weiner, LM	1
Michaelis, M	1
Langer, K	1
Arnold, S	1
Doerr, HW	1
Kreuter, J	1
Cinatl, J	1
Gietema, JA	1
van der Graaf, WT	1
de Korte, MA	1
Jonkman, S	1
van Veldhuisen, DJ	1
Sleijfer, DT	1
Hashemi, M	1
Ghavami, S	1
Eshraghi, M	1
Booy, EP	1
Los, M	1
Hanaoka, H	1
Mukai, T	1
Habashita, S	1
Asano, D	1
Ogawa, K	2
Kuroda, Y	2
Akizawa, H	1
Iida, Y	1
Endo, K	1
Saji, H	1
Chen, Y	1
Xiong, Q	1
Yang, X	1
Huang, Z	1
He, L	1
Orlova, A	1
Tran, T	1
Widström, C	1
Engfeldt, T	1
Eriksson Karlström, A	1
Tolmachev, V	1
Hu, M	1
Vallis, K	2
Rainsbury, RM	2
Ott, RJ	1
Westwood, JH	2
Kalirai, TS	1
Coombes, RC	2
McCready, VR	2
Neville, AM	1
Gazet, JC	1
Lenskaia, OP	2
Wendt, TG	1
Büll, U	1
Kessler, M	3
Eiermann, W	5
Kragh, P	1
Cuschieri, A	1
Hutchinson, F	1
Neil, GD	1
Wisbey, ML	1
Wood, RA	1
Preece, P	1
Clark, J	1
Stomper, PC	2
Herman, S	2
Klippenstein, DL	2
Winston, JS	2
Edge, SB	1
Arredondo, MA	1
Mazurchuk, RV	1
Blumenson, LE	1
Boetes, C	2
Mus, RD	2
Holland, R	2
Barentsz, JO	2
Strijk, SP	1
Wobbes, T	1
Hendriks, JH	2
Ruys, SH	2
Kaiser, WA	3
Whitehouse, GH	1
Moore, NR	2
Schrier, DM	1
Stemmer, SM	1
Johnson, T	1
Kasliwal, R	1
Lear, J	1
Matthes, S	1
Taffs, S	1
Dufton, C	1
Glenn, SD	4
Butchko, G	1
Brenner, RJ	1
Shellock, FG	1
Rothman, BJ	1
Giuliano, A	1
Seibert, C	1
Sommer, T	1
Kreft, B	1
Gieseke, J	3
Schild, HH	3
Kreft, BP	1
Hauswirth, A	1
Elevelt, A	2
Reiser, M	4
Boné, B	3
Aspelin, P	2
Isberg, B	2
Perbeck, L	3
Veress, B	3
Hoffmann, U	2
Brix, G	3
Knopp, MV	3
Hess, T	3
Lorenz, WJ	2
Tofts, PS	1
Berkowitz, B	1
Schnall, MD	2
Chenevert, TL	1
Helvie, MA	1
Aisen, AM	1
Francis, IR	1
Adler, DD	1
Roubidoux, MA	1
Londy, FJ	1
Sijens, PE	2
van Dijk, P	2
Oudkerk, M	2
Buckley, DL	4
Kerslake, RW	2
Blackband, SJ	1
Horsman, A	5
Müller-Schimpfle, M	2
Rieber, A	1
Kurz, S	2
Stern, W	2
Claussen, CD	2
Fox, JN	3
Carleton, PJ	3
Imrie, MJ	1
Cook, AM	1
Bowsley, SJ	2
Dean, KI	1
Komu, M	1
Dean, PB	1
Kormano, M	1
van der Sluis, RF	1
van Erning, LJ	1
Doyle, AJ	1
Alder, SL	1
Rohr, LR	1
Klengel, S	1
Hietschold, V	1
Schreiber, M	1
Köhler, K	1
Kramer, EL	4
DeNardo, SJ	3
Liebes, L	4
Noz, ME	3
Kroger, L	1
Furmanski, P	4
Ceriani, R	2
Bong, SB	1
VanderLaan, JG	1
Louwes, H	1
Schuurman, JJ	1
Junkermann, H	1
Zuna, I	1
von Fournier, D	1
van Kaick, G	1
Perman, WH	3
Heiberg, EM	1
Grunz, J	1
Herrmann, VM	3
Janney, CG	2
Heywang-Köbrunner, SH	3
Haustein, J	1
Pohl, C	1
Beck, R	3
Lommatzsch, B	1
Untch, M	2
Nathrath, WB	1
Schmitt, R	1
Helmberger, T	1
Fellner, F	1
Obletter, N	1
Rigauts, H	1
Casselman, J	1
Steyaert, L	1
Devlies, F	1
Pattyn, G	1
Hickman, PF	1
Shepstone, BJ	1
Kroger, LA	1
Mizrachi, H	1
Salako, QA	2
DeNardo, GL	2
Flickinger, FW	1
Allison, JD	1
Sherry, RM	1
Wright, JC	1
Yemul, S	2
Leon, JA	2
Pozniakoff, T	1
Esser, PD	1
Estabrook, A	2
Ando, K	1
Murakami, M	1
Sano, A	1
Nishizawa, S	1
Masada, T	1
Miyamoto, S	1
Kigami, Y	1
Matsumoto, S	1
Kojima, Y	1
Allgayer, B	1
Lukas, P	1
Loos, W	1
Kersting-Sommerhoff, B	1
Murakami, Y	1
Aoki, M	1
Harada, J	1
Kaltenborn, H	1
Schadmand, S	1
Beck, T	1
Thelen, M	2
Mussurakis, S	3
Turnbull, LW	3
Bronge, L	1
Cohen, EK	1
Leonhardt, CM	1
Shumak, RS	1
Soutar, IC	1
Bukhanov, K	1
Fishell, EK	1
Plewes, DB	1
Fischer, U	5
Westerhof, JP	1
Brinck, U	3
Korabiowska, M	3
Schauer, A	3
Grabbe, E	5
Budnick, RM	1
Stewart, CC	1
Heiberg, EV	2
Vosshenrich, R	2
Kawashima, H	1
Furman-Haran, E	1
Margalit, R	1
Grobgeld, D	1
Degani, H	1
Murray, AD	2
Redpath, TW	2
Needham, G	2
Gilbert, FJ	2
Brookes, JA	2
Eremin, O	1
Seki, T	1
Hachiya, J	1
Nitatori, T	1
Yokoyama, K	1
Fukushima, H	1
Uchigasaki, S	1
Schreiber, WG	1
Palmedo, H	1
Grünwald, F	1
Bender, H	1
Schomburg, A	1
Mallmann, P	1
Krebs, D	1
Biersack, HJ	1
Kopka, L	2
Kahlen, O	1
Buadu, LD	1
Murakami, J	1
Murayama, S	1
Hashiguchi, N	1
Sakai, S	1
Masuda, K	1
Toyoshima, S	1
Kuroki, S	1
Ohno, S	1
Mumtaz, H	1
Hall-Craggs, MA	1
Wotherspoon, A	1
Paley, M	1
Buonaccorsi, G	1
Amin, Z	1
Wilkinson, I	1
Kissin, MW	1
Davidson, TI	1
Taylor, I	1
Bown, SG	1
Sittek, H	2
Müller-Lisse, U	1
Bohmert, H	1
Delpassand, ES	1
Yang, DJ	1
Wallace, S	1
Cherif, A	1
Quadri, SM	1
Price, J	1
Joubert, A	1
Inoue, T	1
Podoloff, DA	1
Hittmair, K	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Phase 3, Prospective, Open-Label, Multicenter Comparison Study of Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients With Known Melanoma or Breast Cancer Who Are Undergoing Lymph Node Mapping[NCT00671918]	Phase 3	186 participants (Actual)	Interventional	2008-04-30	Completed
Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging[NCT03354611]	Phase 2/Phase 3	21 participants (Actual)	Interventional	2018-09-10	Terminated (stopped due to The study progress doesn't meet the sponsor's requirement)
In Vivo Molecular Imaging (MRI) of Atherothrombotic Lesions[NCT01418313]		886 participants (Actual)	Observational	2011-09-30	Completed
A Pilot Study Investigating Neoadjuvant Temozolomide-based Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas[NCT00881595]	Phase 2	0 participants (Actual)	Interventional	2009-02-28	Withdrawn (stopped due to No patients accrued since study opened)
Randomised Controlled Trial of the Effects of Fish Oil Emulsion in Total Parenteral Nutrition Upon Tumour Vascularity in Patients With Hepatic Colorectal Metastases[NCT00942292]	Phase 2	20 participants (Actual)	Interventional	2007-05-31	Completed
Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors[NCT04790708]		250 participants (Anticipated)	Interventional	2018-07-02	Recruiting
Phase I/II Study of Lutathera in Pediatric and Young Adult Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Express Somatostatin Type2A Receptors and Demonstrate Uptake on DOTATATE PET[NCT05278208]	Phase 1/Phase 2	65 participants (Anticipated)	Interventional	2022-11-21	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

The proportion of lymph nodes detected intraoperatively by blue dye that were also detected by Lymphoseek. (NCT00671918)
Timeframe: Surgery after injections of Lymphoseek and blue dye

Reverse Concordance of Blue Dye and Lymphoseek

Intervention	Proportion of Lymph Nodes (Number)
Intent-To-Treat	0.9767

The proportion of lymph nodes detected intraoperatively by Lymphoseek that were also detected by blue dye. (NCT00671918)
Timeframe: Surgery after injections of Lymphoseek and blue dye

Article	Year
The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of care. Clinical & experimental metastasis, 2012, Volume: 29, Issue:7 Topics: Breast Neoplasms; Dextrans; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoscintigraphy; Mannans;	2012
MR imaging of the breast after surgery for breast cancer. Magnetic resonance imaging clinics of North America, 1994, Volume: 2, Issue:4 Topics: Breast; Breast Neoplasms; Cicatrix; Contrast Media; Diagnostic Imaging; Female; Gadolinium; Gadolini	1994
[Gadolinium-DTPA (Magnevist) as contrast medium for galactography]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1995, Volume: 163, Issue:5 Topics: Aged; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Contrast Media; Female	1995
Gadolinium-enhanced breast MRI. Critical reviews in diagnostic imaging, 1995, Volume: 36, Issue:4 Topics: Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imagin	1995
Somatostatin receptors and breast cancer. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1998, Volume: 42, Issue:1 Topics: Autoradiography; Breast Neoplasms; Carcinoma; Cell Differentiation; Female; Gene Expression Regulati	1998
Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide. Clinical endocrinology, 1998, Volume: 49, Issue:5 Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Carcinoi	1998
Somatostatin receptor imaging. Seminars in nuclear medicine, 2002, Volume: 32, Issue:2 Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas	2002
Somatostatin receptor imaging. Seminars in nuclear medicine, 2002, Volume: 32, Issue:2 Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas	2002
Somatostatin receptor imaging. Seminars in nuclear medicine, 2002, Volume: 32, Issue:2 Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas	2002
Somatostatin receptor imaging. Seminars in nuclear medicine, 2002, Volume: 32, Issue:2 Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas	2002
Potential applications of monoclonal antibodies in cancer diagnosis and therapy. Cancer investigation, 1985, Volume: 3, Issue:6 Topics: Adenocarcinoma; alpha-Fetoproteins; Animals; Antibodies, Monoclonal; Antibody Specificity; Antigens,	1985
Nuclear magnetic resonance in the diagnosis of breast cancer. Radiologic clinics of North America, 1988, Volume: 26, Issue:3 Topics: Breast Neoplasms; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Im	1988

Article	Year
Phase I trial of intraoperative detection of tumor margins in patients with HER2-positive carcinoma of the breast following administration of 111In-DTPA-trastuzumab Fab fragments. Nuclear medicine and biology, 2013, Volume: 40, Issue:5 Topics: Antibodies, Monoclonal, Humanized; Breast Neoplasms; Feasibility Studies; Female; Humans; Immunoglob	2013
Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol. Nuclear medicine and biology, 2009, Volume: 36, Issue:6 Topics: Aged; Breast Neoplasms; Dextrans; Female; Humans; Injections, Intradermal; Lymph Nodes; Mannans; Mid	2009
A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer. Annals of surgical oncology, 2011, Volume: 18, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Dextrans; Female; Humans; Lymph Nodes; Lymphatic M	2011
Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Annals of surgical oncology, 2003, Volume: 10, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Dextrans; Female; Humans; Injections, Subcutaneous; Lymphatic Metasta	2003
Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping. Nuclear medicine and biology, 2003, Volume: 30, Issue:8 Topics: Adult; Aged; Breast Neoplasms; Dextrans; Dose-Response Relationship, Drug; Female; Humans; Injection	2003
Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek. Nuclear medicine and biology, 2007, Volume: 34, Issue:7 Topics: Aged; Aged, 80 and over; Breast Neoplasms; Dextrans; Female; Humans; Injections, Intradermal; Lymph	2007
High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial. Cancer research, 1995, Dec-01, Volume: 55, Issue:23 Suppl Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Female; H	1995
Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody. Advances in experimental medicine and biology, 1994, Volume: 353 Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibody Specificity; Biomarkers, Tumor	1994
Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:7 Topics: Breast Neoplasms; Chelating Agents; Female; Humans; Indium Radioisotopes; Middle Aged; Neoplasm Meta	1993
Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma. The British journal of radiology, 1996, Volume: 69, Issue:823 Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Long-Term Care; Magn	1996
Observer variability in the interpretation of contrast enhanced MRI of the breast. The British journal of radiology, 1996, Volume: 69, Issue:827 Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Hum	1996
Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours. Clinical radiology, 1997, Volume: 52, Issue:7 Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fibroadenoma; Gadoli	1997
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:8 Topics: Breast Neoplasms; Chelating Agents; Female; Humans; Indium Radioisotopes; Middle Aged; Pentetic Acid	1997
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:10 Suppl Topics: Animals; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Female; Hematopoieti	1999

Article	Year
Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging. Radiology, 2018, Volume: 286, Issue:2 Topics: Animals; Breast Neoplasms; Contrast Media; Female; Ferric Compounds; Gadolinium; Gadolinium DTPA; He	2018
Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas. Nuclear medicine and biology, 2013, Volume: 40, Issue:4 Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic	2013
Trastuzumab labeled to high specific activity with ¹¹¹In by conjugation to G4 PAMAM dendrimers derivatized with multiple DTPA chelators exhibits increased cytotoxic potency on HER2-positive breast cancer cells. Pharmaceutical research, 2013, Volume: 30, Issue:8 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell S	2013
LAT-1 based primary breast cancer detection by [99m]Tc-labeled DTPA-bis-methionine scintimammography: first results using indigenously developed single vial kit preparation. Cancer biotherapy & radiopharmaceuticals, 2014, Volume: 29, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Large Neutral Amino Acid-Transport	2014
Prolonged local retention of subcutaneously injected polymers monitored by noninvasive SPECT imaging. International journal of pharmaceutics, 2014, Dec-10, Volume: 476, Issue:1-2 Topics: Acetylation; Animals; Breast Neoplasms; Collagen; Delayed-Action Preparations; Dendrimers; Drug Deli	2014
Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2015, Volume: 96 Topics: Animals; Bombesin; Breast Neoplasms; Cell Line, Tumor; Drug Stability; Female; Heterocyclic Compound	2015
Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting (111)In-Trastuzumab for Potential Combination Therapies. Cancer biotherapy & radiopharmaceuticals, 2015, Volume: 30, Issue:8 Topics: Bortezomib; Breast Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Radiation; Drug Screenin	2015
Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer. Pharmaceutical research, 2017, Volume: 34, Issue:2 Topics: Antibodies, Bispecific; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug	2017
Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors. Annals of nuclear medicine, 2008, Volume: 22, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoid Tumor; Chromogranin A	2008
Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:8 Topics: Active Transport, Cell Nucleus; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA	2008
Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software. International journal of radiation biology, 2009, Volume: 85, Issue:3 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; DNA Breaks, Double-Stranded; Dose-Response Relatio	2009
Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors. Bioconjugate chemistry, 2009, Aug-19, Volume: 20, Issue:8 Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Indium Radioisotopes; L	2009
In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy. Nuclear medicine and biology, 2009, Volume: 36, Issue:7 Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neop	2009
Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy. Molecular pharmaceutics, 2010, Feb-01, Volume: 7, Issue:1 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Electrons; Epidermal	2010
Synthesis of a novel antiestrogen radioligand (99mTc-TOR-DTPA). Cancer biotherapy & radiopharmaceuticals, 2009, Volume: 24, Issue:6 Topics: Animals; Breast Neoplasms; Chromatography, High Pressure Liquid; Estrogen Receptor Modulators; Femal	2009
A kit to prepare (111)In-DTPA-trastuzumab (Herceptin) Fab fragments injection under GMP conditions for imaging or radioimmunoguided surgery of HER2-positive breast cancer. Nuclear medicine and biology, 2011, Volume: 38, Issue:1 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Chemi	2011
Diethylenetriamine pentaacetic acid derivative of toremifene and in vitro evaluation in human breast cancer cell line MCF-7. Cancer biotherapy & radiopharmaceuticals, 2011, Volume: 26, Issue:1 Topics: Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent As	2011
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates. Cancer research, 2011, Jul-01, Volume: 71, Issue:13 Topics: Amino Acid Sequence; Animals; Antibodies; Breast Neoplasms; Carbocyanines; Cell Line, Tumor; DNA Dam	2011
Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles. Journal of controlled release : official journal of the Controlled Release Society, 2012, Feb-10, Volume: 157, Issue:3 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Chemistry, Pharmaceutical; Epidermal	2012
¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer. Breast cancer research and treatment, 2012, Volume: 135, Issue:1 Topics: Animals; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; DNA Damage; Drug Res	2012
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical. Nuclear medicine and biology, 2012, Volume: 39, Issue:8 Topics: Animals; Bleomycin; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Breaks,	2012
Biotinylated polyacrylamide-based metal-chelating polymers and their influence on antigen recognition following conjugation to a trastuzumab Fab fragment. Biomacromolecules, 2012, Sep-10, Volume: 13, Issue:9 Topics: Acrylic Resins; Antibodies, Monoclonal, Humanized; Biotin; Biotinylation; Breast Neoplasms; Cell Lin	2012
Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors. Biomaterials, 2013, Volume: 34, Issue:4 Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumo	2013
In vitro studies on 5-florouracil-loaded DTPA-PE containing nanosized pegylated liposomes for diagnosis and treatment of tumor. Journal of liposome research, 2013, Volume: 23, Issue:1 Topics: Breast Neoplasms; Contrast Media; Diagnostic Imaging; Female; Fluorouracil; Humans; Liposomes; MCF-7	2013
Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells. Nuclear medicine and biology, 2002, Volume: 29, Issue:6 Topics: Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Doxorubicin; Epidermal Growth Factor; Er	2002
Pharmacokinetics of (111)In-labeled triplex-forming oligonucleotide targeting human N-myc gene. Molecules and cells, 2002, Aug-31, Volume: 14, Issue:1 Topics: Animals; Breast Neoplasms; DNA; Female; Genes, myc; Humans; Indium Radioisotopes; Mice; Mice, Inbred	2002
Preparation and comparative evaluation of 99mTc-labeled 2-iminothiolane modified antibodies and CITC-DTPA immunoconjugates of anti-EGF-receptor antibodies. Methods and findings in experimental and clinical pharmacology, 2002, Volume: 24, Issue:10 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Breast Neoplasms; Central Nervo	2002
111In-labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumours. The British journal of surgery, 2003, Volume: 90, Issue:5 Topics: Adult; Aged; Biopsy; Breast Neoplasms; Chelating Agents; Female; Hormones; Humans; Immunohistochemis	2003
Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:3 Topics: Antibodies, Monoclonal; Breast Neoplasms; Female; Humans; Immunoconjugates; Immunoglobulin G; Indium	2003
Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:9 Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Dose-Response Relationship, Radiation; Drug Delivery S	2003
Preclinical characterisation of 111In-DTPA-trastuzumab. British journal of pharmacology, 2004, Volume: 143, Issue:1 Topics: Animals; Breast Neoplasms; Drug Stability; Immunohistochemistry; Indium; Isotope Labeling; Mice; Mic	2004
A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice. Cancer research, 2004, Sep-01, Volume: 64, Issue:17 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Immunoglobulin Variable Region; Immunot	2004
Pharmacological activity of DTPA linked to protein-based drug carrier systems. Biochemical and biophysical research communications, 2004, Oct-29, Volume: 323, Issue:4 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Drug Carrie	2004
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, May-20, Volume: 24, Issue:15 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chem	2006
Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:6 Topics: Animals; Body Burden; Breast Neoplasms; Drug Evaluation, Preclinical; Electrons; Epidermal Growth Fa	2006
Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells. European journal of pharmacology, 2007, Feb-14, Volume: 557, Issue:1 Topics: Acetylcysteine; Apoptosis; Breast Neoplasms; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell	2007
Chemical design of a radiolabeled gelatinase inhibitor peptide for the imaging of gelatinase activity in tumors. Nuclear medicine and biology, 2007, Volume: 34, Issue:5 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Drug Design; Enzyme Activation; Humans; Isotope Labelin	2007
Preparation and imaging research on 188Re-DTPA-deoxyglucose in MCF-7 tumor-bearing mice. Cancer biotherapy & radiopharmaceuticals, 2007, Volume: 22, Issue:3 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Deoxyglucose; Female; Humans; Mice; Mice, Nude; Penteti	2007
Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors. International journal of molecular medicine, 2007, Volume: 20, Issue:3 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Genes, erbB-2; Hu	2007
Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF. Nuclear medicine and biology, 2007, Volume: 34, Issue:8 Topics: Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dose-Response Relationship, Radiati	2007
Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet (London, England), 1983, Oct-22, Volume: 2, Issue:8356 Topics: Antibodies, Monoclonal; Bone Neoplasms; Breast Neoplasms; Chelating Agents; Female; Humans; Indium;	1983
[Radioisotope and thermographic studies in tumorous breast diseases]. Meditsinskaia radiologiia, 1981, Volume: 26, Issue:12 Topics: Adult; Aged; Bleomycin; Breast; Breast Neoplasms; Female; Gallium Radioisotopes; Humans; Indium; Mid	1981
The localization of human breast carcinomas by radiolabelled monoclonal antibodies. The British journal of surgery, 1984, Volume: 71, Issue:10 Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Diphosphonates; Evaluation Studies as Topic; Fema	1984
[Diagnosis of benign and malignant tumors of the female breast using single photon emission computed tomography with 99mTc-DTPA]. Nuklearmedizin. Nuclear medicine, 1984, Volume: 23, Issue:6 Topics: Breast Neoplasms; Female; Humans; Pentetic Acid; Technetium; Technetium Tc 99m Pentetate; Tomography	1984
Neoplastic meningitis. The Johns Hopkins medical journal, 1982, Volume: 151, Issue:2 Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Blood-Brain Barrier; Breast Neoplasms; Cerebrospinal F	1982
Scintiscanning of the breast with 99Tcm-diethylene triamine penta-acetic acid--a prospective blind evaluation. The British journal of surgery, 1981, Volume: 68, Issue:3 Topics: Adult; Aged; Breast; Breast Diseases; Breast Neoplasms; Diagnosis, Differential; False Negative Reac	1981
Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology, 1995, Volume: 197, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma in Situ; Carcinoma, D	1995
Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology, 1995, Volume: 197, Issue:3 Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gad	1995
False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid. Magnetic resonance imaging clinics of North America, 1994, Volume: 2, Issue:4 Topics: Breast; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Contrast Media; False Positive React	1994
Technical note: magnetic resonance imaging-guided pre-operative breast localization using "freehand technique". The British journal of radiology, 1995, Volume: 68, Issue:814 Topics: Breast; Breast Neoplasms; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnet	1995
[Focal and diffuse lesions in dynamic MR-mammography of healthy probands]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1995, Volume: 163, Issue:3 Topics: Adult; Breast; Breast Neoplasms; Contrast Media; Diagnosis, Differential; False Positive Reactions;	1995
[MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1995, Volume: 162, Issue:6 Topics: Breast; Breast Diseases; Breast Neoplasms; Carcinoma; Contrast Media; Diagnosis, Differential; Femal	1995
Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery. Acta radiologica (Stockholm, Sweden : 1987), 1995, Volume: 36, Issue:2 Topics: Breast; Breast Implants; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma,	1995
Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magnetic resonance in medicine, 1995, Volume: 33, Issue:4 Topics: Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Female; Gadolinium DTPA; Humans	1995
Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magnetic resonance in medicine, 1995, Volume: 33, Issue:4 Topics: Breast; Breast Neoplasms; Capillary Permeability; Contrast Media; Female; Gadolinium DTPA; Humans; I	1995
Dynamic three-dimensional imaging with partial k-space sampling: initial application for gadolinium-enhanced rate characterization of breast lesions. Radiology, 1995, Volume: 196, Issue:1 Topics: Adult; Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; I	1995
Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma. Magnetic resonance in medicine, 1994, Volume: 32, Issue:5 Topics: Adult; Aspartic Acid; Brain Neoplasms; Breast Neoplasms; Carcinoma; Choline; Contrast Media; Creatin	1994
Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimization procedure. Magnetic resonance in medicine, 1994, Volume: 32, Issue:5 Topics: Algorithms; Breast Neoplasms; Carcinoma, Ductal, Breast; Computer Simulation; Contrast Media; Female	1994
[Dynamic 3D MR mammography using a rapid gradient-echo sequence]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1995, Volume: 162, Issue:1 Topics: Adolescent; Adult; Aged; Breast; Breast Neoplasms; Carcinoma; Contrast Media; Female; Gadolinium; Ga	1995
Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience. The British journal of radiology, 1994, Volume: 67, Issue:804 Topics: Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Diagnosis, Differential; Female; Gadolin	1994
Magnetization transfer contrast in gadopentetate-dimeglumine-enhanced breast magnetic resonance imaging at 0.1 Tesla. Investigative radiology, 1994, Volume: 29 Suppl 2 Topics: Adult; Aged; Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Drug Combinations; Gadoliniu	1994
MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology, 1994, Volume: 193, Issue:3 Topics: Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Drug Combinations; Female; Gadolinium DTP	1994
Myoepithelial lesions of the breast: imaging characteristics and diagnosis with large-core needle biopsy in two cases. Radiology, 1994, Volume: 193, Issue:3 Topics: Aged; Biopsy, Needle; Breast; Breast Neoplasms; Carcinoma, Adenoid Cystic; Contrast Media; Drug Comb	1994
[Quantitative dynamic contrast breast-MRI with the 0.5 tesla equipment]. Rontgenpraxis; Zeitschrift fur radiologische Technik, 1994, Volume: 47, Issue:8 Topics: Adult; Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; G	1994
Clinical experience with somatostatin receptor imaging in lymphoma. Seminars in oncology, 1994, Volume: 21, Issue:5 Suppl 13 Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Hodgkin Disease; Humans; Indium Radioisoto	1994
[A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1994, Volume: 160, Issue:6 Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Contrast Media; Diagnosis, Differential; Discriminant Anal	1994
A fast 3D-imaging technique for performing dynamic Gd-enhanced MRI of breast lesions. Magnetic resonance imaging, 1994, Volume: 12, Issue:4 Topics: Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assist	1994
Contrast-enhanced magnetic resonance imaging of the breast. Investigative radiology, 1994, Volume: 29, Issue:1 Topics: Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhance	1994
Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology, 1994, Volume: 191, Issue:3 Topics: Breast; Breast Diseases; Breast Neoplasms; Carcinoma; Contrast Media; Drug Combinations; Female; Fib	1994
[The marking of nonpalpable breast tumors in MRT]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1993, Volume: 159, Issue:5 Topics: Biopsy; Breast; Breast Neoplasms; Capsules; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hum	1993
Contribution of MRI and color Doppler sonography in breast cancer diagnosis. Journal belge de radiologie, 1993, Volume: 76, Issue:4 Topics: Adult; Aged; Breast Neoplasms; Cicatrix; Contrast Media; Female; Fibroadenoma; Fibrocystic Breast Di	1993
The indeterminate breast mass: assessment using contrast enhanced magnetic resonance imaging. The British journal of radiology, 1994, Volume: 67, Issue:793 Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Gad	1994
Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magnetic resonance imaging, 1993, Volume: 11, Issue:5 Topics: Adenofibroma; Adult; Aged; Breast Neoplasms; Contrast Media; Female; Fibrocystic Breast Disease; Gad	1993
Radioimmunoimaging of human breast carcinoma xenografts in nude mouse model with 111In-labeled new monoclonal antibody EBA-1 and F(ab')2 fragments. Nuclear medicine and biology, 1993, Volume: 20, Issue:3 Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Blotting, Western; Breast Neoplasms; Chemical Ph	1993
[Clinical utility of Gd-DTPA subtraction MR imaging for spinal bone metastasis]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1993, Feb-25, Volume: 53, Issue:2 Topics: Adult; Aged; Breast Neoplasms; Female; Gadolinium DTPA; Humans; Lung Neoplasms; Magnetic Resonance I	1993
[The MRT of the breast with 2D-spin-echo and gradient-echo sequences in diagnostically problematic cases]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1993, Volume: 158, Issue:5 Topics: Adult; Biopsy; Breast; Breast Neoplasms; Contrast Media; Evaluation Studies as Topic; Female; Gadoli	1993
[Subtraction and dynamic MR images of breast cancer]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1993, Apr-25, Volume: 53, Issue:4 Topics: Adenofibroma; Adolescent; Adult; Aged; Breast Neoplasms; Female; Gadolinium DTPA; Humans; Image Enha	1993
Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma. Investigative radiology, 1995, Volume: 30, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma; Carcinoma in Situ; Carcinoma, D	1995
Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta radiologica (Stockholm, Sweden : 1987), 1996, Volume: 37, Issue:2 Topics: Breast Neoplasms; Contrast Media; False Negative Reactions; False Positive Reactions; Female; Gadoli	1996
Magnetic resonance imaging in potential postsurgical recurrence of breast cancer: pitfalls and limitations. Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 1996, Volume: 47, Issue:3 Topics: Aged; Biopsy; Breast Diseases; Breast Neoplasms; Carcinoma; Contrast Media; False Negative Reactions	1996
[Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1996, Volume: 164, Issue:4 Topics: Adult; Aged; Biomarkers, Tumor; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Brea	1996
Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. Cancer, 1996, May-01, Volume: 77, Issue:9 Topics: Adult; Aged; Aneuploidy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Divis	1996
Half-Fourier, three-dimensional technique for dynamic contrast-enhanced MR imaging of both breasts and axillae: initial characterization of breast lesions. Radiology, 1996, Volume: 200, Issue:1 Topics: Adult; Axilla; Breast; Breast Neoplasms; Contrast Media; Female; Fourier Analysis; Gadolinium DTPA;	1996
[MRI-controlled intervention in suspected lesions of the breast]. Geburtshilfe und Frauenheilkunde, 1996, Volume: 56, Issue:4 Topics: Biopsy, Needle; Breast; Breast Neoplasms; Contrast Media; Equipment Design; Female; Gadolinium DTPA;	1996
[Fat suppressed dynamic MR imaging of breast cancer: radiologic-pathologic correlation]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1996, Volume: 56, Issue:7 Topics: Adenocarcinoma, Scirrhous; Adipose Tissue; Adult; Aged; Breast Neoplasms; Female; Gadolinium DTPA; H	1996
Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. Proceedings of the National Academy of Sciences of the United States of America, 1996, Jun-25, Volume: 93, Issue:13 Topics: Animals; Breast Neoplasms; Capillary Permeability; Contrast Media; Female; Gadolinium DTPA; Humans;	1996
[MR imaging for breast cancer]. Nihon Geka Gakkai zasshi, 1996, Volume: 97, Issue:5 Topics: Adult; Biopsy, Needle; Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Ma	1996
Improved visualization of breast lesions with gadolinium-enhanced magnetization transfer MR imaging. Magnetic resonance in medicine, 1996, Volume: 35, Issue:6 Topics: Adult; Aged; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Female; Fibrocysti	1996
Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. European journal of nuclear medicine, 1996, Volume: 23, Issue:8 Topics: Biopsy; Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonanc	1996
[Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast]. Bildgebung = Imaging, 1996, Volume: 63, Issue:2 Topics: Biopsy; Breast; Breast Neoplasms; Combined Modality Therapy; Contrast Media; Drug Combinations; Fema	1996
Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology, 1996, Volume: 200, Issue:3 Topics: Adult; Aged; Breast; Breast Neoplasms; Breast Neoplasms, Male; Contrast Media; Drug Combinations; Fe	1996
Laser therapy for breast cancer: MR imaging and histopathologic correlation. Radiology, 1996, Volume: 200, Issue:3 Topics: Adult; Aged; Breast; Breast Neoplasms; Contrast Media; Drug Combinations; Female; Gadolinium; Gadoli	1996
[Technics for the preoperative marking of nonpalpable breast lesions in MRT]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1996, Volume: 165, Issue:1 Topics: Breast; Breast Neoplasms; Charcoal; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Mag	1996
Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue. Journal of pharmaceutical sciences, 1996, Volume: 85, Issue:6 Topics: Animals; Autoradiography; Breast Neoplasms; Estradiol; Female; Humans; Indium Radioisotopes; Kinetic	1996
Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magnetic resonance imaging, 1996, Volume: 14, Issue:4 Topics: Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Image Processing, Compute	1996
Measurement of spin-lattice relaxation times with FLASH for dynamic MRI of the breast. The British journal of radiology, 1996, Volume: 69, Issue:819 Topics: Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mammo	1996
Field strength dependence of MRI contrast enhancement: phantom measurements and application to dynamic breast imaging. The British journal of radiology, 1996, Volume: 69, Issue:819 Topics: Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Reson	1996
Effects of partial volume and phase shift between fat and water in gradient-echo magnetic resonance-mammography. Magma (New York, N.Y.), 1996, Volume: 4, Issue:2 Topics: Breast; Breast Neoplasms; Evaluation Studies as Topic; Fats; Female; Gadolinium DTPA; Humans; Lipids	1996
1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR in biomedicine, 1996, Volume: 9, Issue:2 Topics: Brain Neoplasms; Breast Neoplasms; Gadolinium DTPA; Humans; Lactates; Lipids; Lung Neoplasms; Magnet	1996
Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging. Radiology, 1997, Volume: 202, Issue:1 Topics: Adult; Aged; Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Dru	1997
Breast MRI: early experience with a 3-D fat-suppressed gradient echo sequence in the evaluation of breast lesions. Australasian radiology, 1996, Volume: 40, Issue:4 Topics: Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Female; Fourier Analysis; Gadol	1996
Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology, 1997, Volume: 202, Issue:2 Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Drug Combin	1997
Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Zentralblatt fur Gynakologie, 1997, Volume: 119, Issue:1 Topics: Aged; Aged, 80 and over; Biopsy; Breast; Breast Neoplasms; Contrast Media; Diagnosis, Differential;	1997
Computed model of gadolinium enhanced MRI of breast disease. European journal of radiology, 1997, Volume: 24, Issue:2 Topics: Algorithms; Breast; Breast Neoplasms; Computer Simulation; Contrast Media; Data Display; Female; Gad	1997
Solitary breast metastasis as the first sign of a squamous cell carcinoma of the cervix: imaging findings. European journal of radiology, 1997, Volume: 24, Issue:2 Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hum	1997
Magnetic resonance galactography for a patient with nipple discharge. Breast cancer research and treatment, 1997, Volume: 42, Issue:1 Topics: Adult; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Gadolinium; Gadoliniu	1997
Do mammography, sonography, and MR mammography have a diagnostic benefit compared with mammography and sonography? AJR. American journal of roentgenology, 1997, Volume: 168, Issue:5 Topics: Breast; Breast Neoplasms; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Female; Ga	1997
The variability of fibroadenoma in contrast-enhanced dynamic MR mammography. AJR. American journal of roentgenology, 1997, Volume: 168, Issue:5 Topics: Adult; Breast; Breast Neoplasms; Contrast Media; Drug Combinations; Female; Fibroadenoma; Gadolinium	1997
Comparison of indium-111 octreotide and thallium-201 scintigraphy in patients mammographically suspected of having breast cancer: preliminary results. European journal of nuclear medicine, 1997, Volume: 24, Issue:3 Topics: Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Indium Radioisotopes;	1997
MRI diagnosis of intramedullary metastases from extra-CNS tumors. European radiology, 1997, Volume: 7, Issue:5 Topics: Breast Neoplasms; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Lung Neoplasms; Magne	1997
[Contrast media in MR mammography]. Aktuelle Radiologie, 1997, Volume: 7, Issue:2 Topics: Breast; Breast Neoplasms; Contrast Media; Equipment Design; Female; Gadolinium DTPA; Humans; Image P	1997
Multiple giant fibroadenomas: clinical presentation and radiologic findings. Gynecologic and obstetric investigation, 1997, Volume: 43, Issue:4 Topics: Adult; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fibroadenoma; Gadolinium; Humans;	1997
Is there a correlation in breast carcinomas between tumor size and number of tumor vessels detected by gadolinium-enhanced magnetic resonance mammography? Magma (New York, N.Y.), 1997, Volume: 5, Issue:1 Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Contrast Media; Female; Fibroadenoma; Gadolinium DTPA; Hum	1997
Magnetic resonance ventriculography with gadolinium DTPA: report of two cases. Neuroradiology, 1997, Volume: 39, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cerebral Ventricles; Contrast Medi	1997
Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta radiologica (Stockholm, Sweden : 1987), 1997, Volume: 38, Issue:4 Pt 1 Topics: Breast; Breast Diseases; Breast Neoplasms; Contrast Media; False Negative Reactions; False Positive	1997
Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR. American journal of roentgenology, 1997, Volume: 169, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium; Gadoli	1997
MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration. Skeletal radiology, 1997, Volume: 26, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Bone Marrow; Bone Marrow Neoplasms; Breast Neopla	1997
Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. European radiology, 1997, Volume: 7, Issue:7 Topics: Biomarkers, Tumor; Breast; Breast Neoplasms; Contrast Media; ErbB Receptors; Female; Gadolinium; Gad	1997
Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology, 1997, Volume: 205, Issue:1 Topics: Adult; Aged; Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans;	1997
Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Radiology, 1997, Volume: 205, Issue:1 Topics: Adult; Aged; Biopsy, Needle; Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Female; Gado	1997
[A rare differential diagnosis of suspicious contrast medium enhancement in breast MRI. Melanoma metastasis in both breasts]. Der Radiologe, 1997, Volume: 37, Issue:7 Topics: Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imagin	1997
Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:7 Topics: Adult; Antibodies, Monoclonal; Breast Neoplasms; Female; Humans; Indium Radioisotopes; Middle Aged;	1998
Tumor imaging via indium 111-labeled DTPA-adenosylcobalamin. Mayo Clinic proceedings, 1999, Volume: 74, Issue:7 Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cobamides; Female; Humans; Indium Radioisotopes; Middle	1999
A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:5 Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Epidermal Growth Factor; ErbB Receptors; Female;	2000
Tc-99m sestamibi and In-111 DTPA octreotide uptake in breast carcinoma with neurendocrine differentiation. Clinical nuclear medicine, 2000, Volume: 25, Issue:6 Topics: Aged; Breast Neoplasms; Carcinoma; Carcinoma, Neuroendocrine; Diagnosis, Differential; Female; Human	2000
Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts. Cancer research, 2001, Apr-01, Volume: 61, Issue:7 Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Bone Marrow; Breast Neoplasms; Ce	2001
Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:4 Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Breast Neoplasms; Disease Models, Animal; Female	2001
Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL. The Journal of surgical research, 2001, May-15, Volume: 97, Issue:2 Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Breast Neoplasms; Contrast Media; Female; Humans; In V	2001
[111Indium-DTPA-D-phe] octreotide scintigraphy in the diagnostic assessment of palpable breast lumps. International journal of surgical investigation, 1999, Volume: 1, Issue:1 Topics: Adult; Aged; Biopsy, Needle; Breast Diseases; Breast Neoplasms; Female; Humans; Middle Aged; Neoplas	1999
In vitro cytotoxicity of bismuth-213 (213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cells. Breast cancer research and treatment, 2002, Volume: 71, Issue:2 Topics: Bismuth; Breast Neoplasms; Cell Survival; Female; Humans; Kinetics; Neoplasm Metastasis; Pentetic Ac	2002
True positive somatostatin receptor scintigraphy in primary breast cancer correlates with expression of sst2A and sst5. Breast cancer research and treatment, 2002, Volume: 72, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Breast Neoplasms; False Negative Reactions; Female; Huma	2002
Clinical efficacy of a large-field-of-view scintillation camera. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1975, Volume: 16, Issue:12 Topics: Aged; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Bronchitis; Cerebrovascular Disorders; Coll	1975
[MR tomography of cystosarcoma phylloides. A case report]. Aktuelle Radiologie, 1992, Volume: 2, Issue:6 Topics: Breast Neoplasms; Child; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Reson	1992
[Lobular carcinoma of the breast in magnetic resonance tomography. A case report]. Aktuelle Radiologie, 1992, Volume: 2, Issue:6 Topics: Breast Neoplasms; Carcinoma; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic R	1992
Exclusion of residual angiosarcoma of the breast by MRI. Breast cancer research and treatment, 1992, Volume: 21, Issue:3 Topics: Adult; Breast Neoplasms; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Hemangiosarcoma	1992
[MR mammography in patients at risk]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1992, Volume: 156, Issue:6 Topics: Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic	1992
Magnetization transfer contrast in fat-suppressed steady-state three-dimensional MR images. Magnetic resonance in medicine, 1992, Volume: 26, Issue:1 Topics: Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Image	1992
[Enhanced MRI of breast cancer smaller than 3 cm]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1991, Nov-25, Volume: 51, Issue:11 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Scirrhous; Adult; Aged; Aged, 80 and over;	1991
[Dynamic imaging with magnetic resonance in the diagnosis of breast disease]. La Radiologia medica, 1991, Volume: 82, Issue:4 Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fol	1991
[The feasibility of magnetic resonance tomography in the diagnosis of non-palpable breast tumors]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1991, Volume: 154, Issue:1 Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic	1991
Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast. AJR. American journal of roentgenology, 1991, Volume: 157, Issue:2 Topics: Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mammo	1991
Immunohistochemical and pharmacokinetic characterization of site-specific immunoconjugate 15A8-glycyl-tyrosyl-(N-epsilon-diethylenetriamine pentaacetic acid)-lysine derived from anti-breast carcinoma monoclonal antibody 15A8. Cancer research, 1991, Oct-15, Volume: 51, Issue:20 Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; Breast Neoplasms; Female; Hu	1991
Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress. Radiology, 1991, Volume: 181, Issue:3 Topics: Adult; Aged; Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Drug Combinations; Fat Necro	1991
Tumor localization in nude mice bearing human breast carcinoma xenografts using 111In-DTPA conjugates of monoclonal antibodies. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1991, Volume: 18, Issue:3 Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line; Enzyme-Linked Immunosorbent Assay; Fem	1991
[MRT of brain metastases. (I) What is the place of screening with T2-weighted sequences?]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1990, Volume: 153, Issue:3 Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Carcinoma, Bronchogenic; Gadolinium; Gadolinium DTPA	1990
Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology, 1990, Volume: 174, Issue:2 Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Carcinoma; Contrast Media; Female; Fibrocystic Breas	1990
Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Radiology, 1986, Volume: 158, Issue:2 Topics: Adult; Animals; Breast Neoplasms; Cell Line; Contrast Media; Female; Gadolinium; Humans; Magnetic Re	1986
MR imaging of the breast with Gd-DTPA: use and limitations. Radiology, 1989, Volume: 171, Issue:1 Topics: Adenofibroma; Breast Neoplasms; Carcinoma; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Huma	1989
[Specific and non-specific contrast media for MRI of tumors. Experimental study of human breast carcinoma]. Journal de radiologie, 1989, Volume: 70, Issue:2 Topics: Animals; Breast Neoplasms; Contrast Media; Cyclic N-Oxides; Female; Gadolinium DTPA; Humans; Magneti	1989
[Nuclear magnetic resonance tomography using gadolinium-DTPA in the diagnosis of spinal lesions]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1988, Volume: 148, Issue:4 Topics: Breast Neoplasms; Cicatrix; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance	1988
MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology, 1989, Volume: 170, Issue:3 Pt 1 Topics: Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Huma	1989
[Use of Gd-DTPA in the nuclear magnetic resonance study of the breast]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1986, Volume: 145, Issue:5 Topics: Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Humans; Magne	1986
[Thermography and radionuclide scintigraphy in reconstructive plastic operations following radical mastectomy]. Meditsinskaia radiologiia, 1987, Volume: 32, Issue:6 Topics: Adult; Breast; Breast Neoplasms; Female; Fibrosis; Follow-Up Studies; Humans; Mastectomy; Middle Age	1987
Scintigraphy of the female breast with Tc-99m-DTPA: a prospective blind evaluation. American journal of physiologic imaging, 1986, Volume: 1, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Breast Neoplasms; Drug Evaluation; Female; Humans; M	1986
[Isolated cervical intramedullary metastasis from breast cancer. Value of magnetic resonance imaging]. Revue neurologique, 1988, Volume: 144, Issue:1 Topics: Adenocarcinoma; Adult; Breast Neoplasms; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans	1988
[Dynamic contrast medium studies with flash sequences in nuclear magnetic resonance tomography of the breast]. Digitale Bilddiagnostik, 1988, Volume: 8, Issue:1 Topics: Breast; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fibrocystic Breast Diseas	1988
[Contrast enhancement of the nipple in nuclear magnetic resonance tomography of the breast with Gd-DTPA]. Digitale Bilddiagnostik, 1987, Volume: 7, Issue:4 Topics: Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Gadolinium; H	1987
The effect of chelating agents on the distribution of monoclonal antibodies in mice. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986, Volume: 27, Issue:11 Topics: 2,2'-Dipyridyl; Animals; Antibodies, Monoclonal; Breast Neoplasms; Chelating Agents; Deferoxamine; E	1986
[Thermographic and radionuclide studies in the combined diagnosis of breast cancer]. Meditsinskaia radiologiia, 1986, Volume: 31, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Pentetic Acid; Radionuclide Imaging; Tec	1986
Breast scintigraphy with 99mTc-diethylene triamine penta-acetic acid for the detection of malignant disease. The British journal of surgery, 1986, Volume: 73, Issue:8 Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Pentetic Acid; Pros	1986
Contrast-enhanced magnetic resonance imaging of tumours of the central nervous system: a clinical review. The British journal of radiology, 1986, Volume: 59, Issue:705 Topics: Astrocytoma; Brain Neoplasms; Breast Neoplasms; Female; Gadolinium; Humans; Magnetic Resonance Spect	1986

pentetic acid and Breast Cancer